Autologous Stem Cell Transplant therapy(Eastern Cooperative Oncology Group)

N/A

Report date: 2026/05/06 20:02:28

Base Information

Drug NameAutologous Stem Cell Transplant therapy(Eastern Cooperative Oncology Group)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsLymphoma, T-Cell, PeripheralLymphoma, Large-Cell, AnaplasticLymphoma, T-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesEastern Cooperative Oncology Group
China Registration ClassN/A

Develop Information

Active CompaniesEastern Cooperative Oncology Group
Inactive CompaniesN/A
Active IndicationsLymphoma, T-Cell, PeripheralLymphoma, Large-Cell, AnaplasticLymphoma, T-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A